GlassScriptPhysician profile
Soroush Bazargani
NPI 1053859041
$3,908.40
in general payments reported to CMS, 2019-2025
20 companies · $1,145 in 2025
The $1,145 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $112 · 2022: $524 · 2023: $698 · 2024: $1,181 · 2025: $1,145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,767 · Travel and Lodging: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,766.78 |
| Travel and Lodging | $256.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $727.79 | 2020-2025 | Titan |
| Boston Scientific Corporation | $627.03 | 2022-2025 | Lithovue, Rezum Generator, Ams 700 |
| Procept Biorobotics Corporation | $613.63 | 2024 | Aquabeam System |
| Teleflex LLC | $559.62 | 2022-2025 | Urolift, Barrigel |
| Karl Storz Endoscopy-America | $295.65 | 2019-2024 | Flex-X, Hopkins |
| Olympus America INC. | $143.49 | 2025 | Itind System |
| Profound Medical Corp. | $133.70 | 2022 | |
| Progenics Pharmaceuticals, INC. | $126.56 | 2025 | |
| Axonics, INC. | $125.99 | 2022 | |
| Abbvie INC. | $112.26 | 2025 | |
| Janssen Biotech, INC. | $108.33 | 2019 | |
| Urogen Pharma, INC. | $89.09 | 2025 | |
| Srs Medical Systems, INC. | $61.32 | 2025 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Mimedx Group, INC. | $60.22 | 2025 | |
| Polynovo North America LLC | $28.98 | 2025 | Novosorb Btm |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $27.15 | 2024 | Arista Ah Flexitip |
| Xeris Pharmaceuticals, INC. | $20.70 | 2025 | Gvoke Hypopen |
| Innovation Technologies INC | $17.31 | 2025 | Irrisept |
| Verity Pharmaceuticals INC. | $15.41 | 2025 | Trelstar |
| Endo USA, INC. | $14.17 | 2025 | Xiaflex, Aveed |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soroush Bazargani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.